Gene array transcript profiling of human endothelial cells identifies pathways regulated by Drotrecogin alfa (activated)

Documenti analoghi

• Drotregocin alfa (activated) inhibits degradation of cytokine-mRNA in an endothelial model of inflammation
  di: Brueckmann, M, et al.
  Pubblicazione: (2003)
• Recombinant human activated protein C upregulates cyclooxygenase-2 and release of prostaglandins from cultured human endothelial cells via the endothelial protein C receptor
  di: Brueckmann, M, et al.
  Pubblicazione: (2004)
• TIMP-1, TIMP-2 and MMP-9 as prognostic markers for clinical outcome in sepsis
  di: Hoffmann, U, et al.
  Pubblicazione: (2003)
• Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
  di: Hoffmann, U, et al.
  Pubblicazione: (2004)
• Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
  di: Launois, R, et al.
  Pubblicazione: (2002)